Download PDF
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2006; 27(04): 32-35
DOI: 10.1055/s-0041-1733191
Case Report

Hepatocellular Carcinoma Presenting with Troublesome Hypoglycemia

Indumati Ambulkar
Department of Medical Oncology,Asian Institute of Oncology S. L. Raheja Hospital Raheja Hospital Road, Mahim West, Mumbai -400 016, India
,
P Jagannath
Department of Gastroenterologic Oncology, Asian Institute of Oncology S. L. Raheja Hospital Raheja Hospital Road, Mahim West, Mumbai -400 016, India
,
Suresh Advani
Department of Medical Oncology,Asian Institute of Oncology S. L. Raheja Hospital Raheja Hospital Road, Mahim West, Mumbai -400 016, India
› Author Affiliations
› Further Information
Also available at
  PDF Download Permissions and Reprints


Publication History

Article published online:
23 March 2022

© 2006. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Beasley RP,Hwang LY,Lin cc,et al. Hepatocellular carcinoma and hepatitis B virus.A prospective study of 22,707 men in Taiwan.Lancet 1981;2:1129
  • 2 Chu CW, Hwang SJ, Luo JC, et al. Manifestations of hypercholesterolaemia, hypoglycaemia, erythrocytosis and hypercalcaemia in patients with hepatocellular carcinoma: report of two cases. J.Gastroenterol Hepatol. 1999;14(8):807-10.
  • 3 Jayaprasad N,T. Anees, T.Bijin,et al.Severe hypoglycemia due to poorly differentiated hepatocellular carcinoma.JAPI.Vol.54;413-415.
  • 4 Nadler WH, Wolfer JA. Hepatogenic hypoglycemia associated with primary liver cell carcinoma. Arch Intern Med 1929;44:700-5.
  • 5 McFadzean A J,Yeung R T.et al. Further observation on hypoglycemia in HCC. Am J Med 1969;47:220-235.
  • 6 Kahn CR. The riddle of tumour hypoglycaemia revisited. J Clin Endocrinol Metab 1980;9:335-60.
  • 7 Megyesi K, Kahn C R, Roth J et al. Hypoglycemia in association with extrapancreatic tumours: demonstration of elevated plasma NSILAs by a new radioreceptor assay. J Clin Endocrinol Metab.1974;38:931- 934.
  • 8 Scharf JG, Braulke T. The role of the IGF axis in hepatocarcinogenesis. Horm Metab Res. 2003;35:(11- 12):685-93.
  • 9 Luo JC, Hwang SJ, Wu JC, et al. Clinical characteristics and prognosis of hepatocellular carcinoma patients with paraneoplastic syndromes. Hepatogastroenterology. 2002;49(47):1315-9.
  • 10 Mazziotti G, Sorvillo F, Morisco F, et al. Serum insulinlike growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study. Cancer. 2002;15;95(12):2539- 45.
  • 11 Stuver SO, Kuper H, Tzonou A,et al.Insulin-like growth factor 1 in hepatocellular carcinoma and metastatic liver cancer in men. Int J Cancer. 2000;1;87(1):118-21.
  • 12 Parikh PM,Fuloria J, Babu G, et al.A phase II study of gemcitabine and carboplatin in patients with advanced hepatocellular carcinoma.Trop Gastroenterol. 2005;26(3):115-8.